Clinical Psychology and Psychotherapy, University of Zurich, Zurich, Switzerland; University Research Priority Program Dynamics of Healthy Aging Research Priority Program, University of Zurich, Zurich, Switzerland.
Clinical Psychology and Psychotherapy, University of Zurich, Zurich, Switzerland; University Research Priority Program Dynamics of Healthy Aging Research Priority Program, University of Zurich, Zurich, Switzerland.
Sex Reprod Healthc. 2020 Dec;26:100559. doi: 10.1016/j.srhc.2020.100559. Epub 2020 Sep 28.
The menopausal transition constitutes a phase of major biopsychosocial changes associated with an elevated risk for the development of depression. Perimenopausal depression is highly prevalent and usually characterized by core symptoms of a major depressive disorder combined with menopausal complaints such as vasomotor symptoms or other physical complaints. However, a distinct definition of the condition is lacking. The aim of this review is to portray the symptoms assessed in studies on perimenopausal depression in order to provide relevant information on the current understanding of this condition. A literature search was conducted using the databases PubMed, Cochrane Library, and PsycINFO. A total of 37 studies were included. Various assessment tools have been used to measure symptoms related to perimenopausal depression. Fifteen symptoms were identified. Depressed mood was assessed across all studies. Low energy or sleep disturbances, as acknowledged symptoms of a major depressive disorder, were surveyed in most studies. However, the assessment of menopausal complaints was rather heterogeneous. While vasomotor symptoms were often measured, other menopausal symptoms such as mood swings or pain were investigated less frequently. Sexual problems were only rarely assessed. Studies on perimenopausal depression regularly include the assessment of core symptoms of a major depressive disorder, but the assessment of menopausal complaints is inconsistent. While certain symptoms are commonly measured, others are not assessed. Such inconsistencies underline an ambiguous understanding of perimenopausal depression, which in turn affects the evaluation and treatment of the condition. Thus, the use of the existing guidelines on perimenopausal depression is recommended.
绝经过渡期是一个主要的生物心理社会变化阶段，与抑郁发生风险增加有关。围绝经期抑郁症的发病率很高，通常表现为重度抑郁症的核心症状，同时伴有绝经期症状，如血管舒缩症状或其他躯体症状。然而，目前对这种疾病还缺乏明确的定义。本综述旨在描述围绝经期抑郁症研究中评估的症状，以便提供对这种疾病目前认识的相关信息。使用 PubMed、Cochrane Library 和 PsycINFO 数据库进行了文献检索。共纳入 37 项研究。各种评估工具被用于测量与围绝经期抑郁症相关的症状。确定了 15 种症状。所有研究都评估了抑郁情绪。低能量或睡眠障碍，作为重度抑郁症的公认症状，在大多数研究中进行了调查。然而，对绝经期症状的评估相当不一致。虽然经常测量血管舒缩症状，但其他如情绪波动或疼痛等绝经期症状的调查较少。性问题很少被评估。围绝经期抑郁症的研究通常包括对重度抑郁症核心症状的评估，但对绝经期症状的评估不一致。虽然某些症状经常被测量，但其他症状则没有被评估。这种不一致性突显了对围绝经期抑郁症理解的模糊性，这反过来又影响了对该疾病的评估和治疗。因此，建议使用现有的围绝经期抑郁症指南。
